secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001493152-25-008116
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix stockholders approve reverse stock split (1:2 to 1:11) and warrant issuance at special meeting
--------------------------------------------------------------------------------

- Reverse stock split approved: 1,560,759 for, 674,302 against; board may set ratio between 1-for-2 and 1-for-11.
- Issuance of shares underlying warrants from Jan 7 Exchange Agreement approved: 417,111 for, 290,431 against, with 1,528,273 broker non-votes.
- Adjournment proposal approved but not needed as sufficient votes existed for both proposals.
- Record date Jan 17, 2025; 6,138,028 shares outstanding; 2,242,618 votes present at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225008116/0001493152-25-008116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225008116/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer